HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder
Clinical trial NCT02252536 · COMPLETED
Trial details
- NCT number
- NCT02252536
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.